<p>The use of aggressive treatment for head and neck cancer (HNC), particularly combined modality treatment regimens, has resulted in an increase in patient survival (American Cancer Society [ACS], 2010). Unfortunately, this improvement has come with a marked increase in acute and late-effects.</p>